Novel Therapy of PAD by Combined Transplantation of BMCs
|ClinicalTrials.gov Identifier: NCT00411840|
Recruitment Status : Unknown
Verified December 2006 by Heinrich-Heine University, Duesseldorf.
Recruitment status was: Recruiting
First Posted : December 15, 2006
Last Update Posted : December 15, 2006
We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.
After 2 and 13 months walking distance and perfusion indices were monitored.
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Arterial Disease||Procedure: intraarterial and intramuscular injection of BMCs||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Transplantation of Autologous Mononuclear Bone Marrow Stem Cells in Patients With Peripheral Arterial Disease (TAM-PAD Study)|
|Study Start Date :||July 2004|
- ABI, walking distance, capillary-venous oxygen saturation, venous occlusion plethysmography
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00411840
|Contact: Thomas Bartsch, MDemail@example.com|
|Duesseldorf, Germany, 40225|
|Contact: Bodo E Strauer, MD +492118118801 firstname.lastname@example.org|
|Principal Investigator: Thomas Bartsch, MD|
|Study Director:||Bodo E Strauer, MD||Heinrich-Heine University, Duesseldorf|